Sandra Milligan insider trades

Open-market stock purchases and sales by Sandra Milligan, Director at Gossamer Bio, Inc, from SEC Form 4 filings since Jun 2, 2021.

Recent trades

DateStockTradeValue
Sep 23, 2026GOSS Gossamer Bio, IncBought (not open market)—
Jun 4, 2026GOSS Gossamer Bio, IncBought (not open market)—
May 27, 2026SYRE Spyre Therapeutics, IncBought (not open market)—

Companies traded

  • GOSS Gossamer Bio, Inc: 2 buys, last Sep 23, 2026
  • SYRE Spyre Therapeutics, Inc: other filings, last May 27, 2026
  • AWH Aspira Women's Health Inc: other filings, last Jan 8, 2025
  • OGN Organon & Co: other filings, last May 4, 2023

Get free alerts when Sandra Milligan files a new trade →